Screening large “libraries” of compounds to find those with a desired biological activity is a powerful method for discovering new drugs, but requires a large, expensive and dedicated facility.
Now, scientists at the Florida campus of The Scripps Research Institute (TSRI) have devised the central component of a screening system that would be orders of magnitude smaller and cheaper.
“We’ve developed a device that can do the functional equivalent of high-throughput compound screening on an ultra-miniaturized scale,” said the study’s principal investigator Brian M. Paegel, an associate professor at TSRI.
The advance, published recently online ahead of print in Analytical Chemistry, follows a previous study from the Paegel laboratory in ACS Combinatorial Science that described the synthesis of miniaturized DNA-encoded compound libraries. The new screening device is designed to work with the new type of library.
Current high-throughput screening systems typically occupy 10,000 square feet of space or more and cost millions of dollars. They rely heavily on robotic devices that retrieve compounds from the library, place each compound into a separate small well in an “assay microplate” and measure each compound’s biological activity—for example, whether the compound inhibits a particular enzyme involved in viral replication.
Being almost entirely automated and relatively quick, such systems can rapidly screen the tens or hundreds of thousands of compounds in a typical library. But the great cost of these high-throughput screening systems limits their use to locations at pharmaceutical companies and large research institutions. The Scripps Florida campus houses one of the most active high-throughput screening facilities outside the pharmaceutical industry.
The new approach starts with the use of “one-bead-one-compound” (OBOC) libraries, in which individual compounds are chemically attached to microscopic beads. Over the past two decades, many laboratories have begun to work with OBOC libraries of one type or another, which are so quickly and cheaply prepared and are so compact that such libraries are essentially laboratory consumables.
“It is possible to generate an OBOC library of millions of compounds in a week for about $500,” said Alexander K. Price, a senior research associate in the Paegel laboratory and lead author of the new study.
There are considerable technical challenges involved in putting bead-borne compounds through miniature screening devices. But, as they report in their new paper, Paegel and Price were able to engineer a benchtop-scale device that meets these challenges and can screen OBOC libraries.
The device is built on the microfluidics principles that also underlie inkjet printer technology. Using a “suspension hopper,” which Paegel and Price described in a 2014 Analytical Chemistry paper, the device introduces OBOC library beads into tiny liquid droplets that contain the assay of interest, such as an enzymatic activity assay. The volume of these assay droplets is about 100,000 times less than the volumes used for high-throughput screening assays.
The device then frees each compound from its bead with a photochemical reaction induced by ultraviolet (UV) light and, after an appropriate period of incubation, records the result in each droplet.
Dubbed LIGHTSABR (Light-Induced and Graduated High-Throughput Screening After Bead Release) for its light-based cleavage of compounds from their carrier beads, the device overcomes significant technical hurdles concerning the smooth flow of droplets, the absorption of stray UV irradiation and calibration of the UV waveguide.
A key innovation is that the technique allows users to vary the UV illumination to adjust the amount of a compound cleaved from its bead—and thus adjust the dose of the compound being tested. The team successfully demonstrated this dosing function using an assay designed to find inhibitors of HIV-1 protease, a key enzyme involved in the replication of the virus that causes AIDS.
The next step for Paegel and Price is to apply the microfluidic LIGHTSABR and the laboratory’s DNA-encoded OBOC libraries. “In addition to antiviral compounds, we are also pursuing new antibiotics and other drug classes that address the emergence of resistance in rapidly evolving pathogens,” said Paegel.
“Hundreds of laboratories around the world could operate their own miniaturized screening facilities, using their own assays to go after targets that are of most interest to them,” said Price.
The Latest on: Portable Drug-Discovery System
via Google News
The Latest on: Portable Drug-Discovery System
- Sommetrics Receives IDE Approval From the FDA to Begin SUPRA Trial of aerSleep II for Treating Sleep Apneaon April 29, 2021 at 7:31 am
Sommetrics is pleased to announce US Food and Drug Administration (FDA) approval of its Investigational Device Exemption (IDE) application to conduct a pivotal in-home clinical trial of its aerSleep ...
- ATTO ThunderLink® Thunderbolt™ 3 to SAS Adapters Featured in Ultra-Portable LTO Tape Storage Solution from Qualstaron April 28, 2021 at 1:45 pm
magnetic tape Qi system to users of macOS devices by including an ATTO ThunderLink® SH 3128 Thunderbolt™ to SAS adapter in a single bundle. The Qualstar Qi Desktop LTO SAS is a compact and portable ...
- Measurement Technologies Making a Difference during the Pandemicon April 20, 2021 at 6:06 pm
Many of Vaisala’s products and systems provide a major contribution in the fight ... Pharmaceutical manufacturers are required to demonstrate process validation from drug discovery to production, and ...
- NEC, D-Wave and the Australian Department of Defence Collaborate on Quantum Computing Initiativeon April 20, 2021 at 12:03 am
We do this by delivering customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, cybersecurity, fault ...
- Belgian artist's 'portable oasis' creates COVID-free bubble for oneon April 19, 2021 at 5:10 am
Alain Verschueren, a Belgian artist and social worker, has been strolling through the capital Brussels wearing a "portable oasis" - a plexiglass mini-greenhouse which rests on his shoulders, cocooning ...
- Linkam FDCS196 stage used in research to develop a novel transdermal delivery system for risperidoneon April 16, 2021 at 6:22 am
The first study of its kind reports on the enhancement of skin permeability of risperidone (RIS) using eutectic systems. A recent study undertaken at the University of Petra in Jordan describes ...
- 2021 Growth Opportunities in Gene Therapies, Cancer, Disease Treatment & Monitoring, Surgical Applications and Cosmetics - ResearchAndMarkets.comon April 16, 2021 at 3:19 am
Further, novel drugs, drug delivery systems, surgical support applications ... and innovations profiled will encompass developments across genetic engineering, drug discovery and development, ...
- A Portable Ebola Detector, 1000x More Sensitive Than Lab-Based Testson April 15, 2021 at 1:30 am
Duke University scientists have created a highly sensitive Ebola virus portable diagnostic device ... high levels early in infection to act as a decoy and distract the immune system while the virus ...
- NVIDIA Partners with Schrödinger to Further Accelerate Drug Discovery Worldwideon April 12, 2021 at 9:23 am
NVIDIA is partnering with Schrödinger to harness NVIDIA DGX A100 systems to further expand the speed and accuracy of Schrödinger’s computational drug discovery platform and enable rapid ...
- Hyperspectral Imaging System Market By Applications - Remote Sensing, Agriculture & Mining/Mineral Mappingon April 12, 2021 at 4:39 am
Whipsmartmi.com offers "Hyperspectral Imaging System MARKET" from its research database. The market IS PROJECTED TO GROW UP TO 19.7% CAGR DURING THE FORECASTING PERIOD 2021-2027. Imaging ...
via Bing News